Description
A comprehensive genetic test that determines hereditary predisposition to breast and ovarian cancer. It is an analysis of the most common genetic markers (BRCA1, BRCA2, CHEK2, NBS1), the presence of which indicates an increased risk of developing an oncological disease.
Period of execution
Within 11 days
Biomaterial type